Literature DB >> 11731418

Microsatellite mutation rates are equivalent in normal and telomerase-immortalized human fibroblasts.

C N Roques1, J C Boyer, R A Farber.   

Abstract

Telomerase-expressing human fibroblasts generally have the same properties as normal cells, except that they have an indefinite life span in culture. We have introduced a dinucleotide repeat sequence into the telomerase-expressing hTERT-1604 cell line and characterized the rates and types of frameshift mutations within this microsatellite. These data have been compared with those in diploid fibroblasts with a finite life span. The rates of mutation were found to be similar in the two cell types, indicating that DNA mismatch repair and other cellular processes responsible for maintenance of mutational stability are not disrupted by telomerase immortalization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731418

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Every microsatellite is different: Intrinsic DNA features dictate mutagenesis of common microsatellites present in the human genome.

Authors:  Kristin A Eckert; Suzanne E Hile
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

2.  Discovery and evaluation of inhibitor of LARP6 as specific antifibrotic compound.

Authors:  Branko Stefanovic; Zarko Manojlovic; Cynthia Vied; Crystal-Dawn Badger; Lela Stefanovic
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

3.  MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

Authors:  J R McDaid; J Loughery; P Dunne; J C Boyer; C S Downes; R A Farber; C P Walsh
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

4.  Experimental design to evaluate directed adaptive mutation in Mammalian cells.

Authors:  Michael Bordonaro; Christopher R Chiaro; Tobias May
Journal:  JMIR Res Protoc       Date:  2014-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.